Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alder

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
The importance of fluctuations in fluid mixingKai Kadau, Charles Rosenblatt, John L Barber, et al.
International Journal of Antimicrobial Agents|November 17, 2012
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE studyJ J De Waele, J M Tellado, J Alder, et al.
The World Journal of Men'S Health|March 24, 2020
Obesity and Baseline Estradiol Levels Are Independent Predictors for Initiation of Anastrozole in Hypogonadal Men on Clomiphene CitrateSorena Keihani, Nathan J Alder, Philip J Cheng, et al.
Infection|November 28, 2012
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF studyN C Schaper, M Dryden, P Kujath, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2004
Nanohydrodynamics simulations: an atomistic view of the Rayleigh-Taylor instabilityKai Kadau, Timothy C Germann, Nicolas G Hadjiconstantinou, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infectionsJ Alder, J Clement, J Meulbroek, et al.
Lancet (London, England)|February 25, 1989
Plasma-derived versus recombinant hepatitis B vaccinesJ B Kurtz, M J Alder, R T Mayon-White, et al.
Journal of Endocrinology and Diabetes|May 26, 2018
Toxic Immunoglobulin Light Chain Autoantibodies are Associated with a Cluster of Severe Complications in Older Adult Type 2 DiabetesMark B Zimering, N Mirkovic, M Pandya, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vitro and in vivo evaluations of A-80556, a new fluoroquinoloneJ J Clement, S K Tanaka, J Alder, et al.
Ophthalmic Epidemiology|August 15, 2024
Cost-Effectiveness of Addressing Retinopathy of Prematurity in RwandaConnor J Alder, Francis Mutangana, Victoria Phillips, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
The importance of fluctuations in fluid mixingKai Kadau, Charles Rosenblatt, John L Barber, et al.
International Journal of Antimicrobial Agents|November 17, 2012
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE studyJ J De Waele, J M Tellado, J Alder, et al.
The World Journal of Men'S Health|March 24, 2020
Obesity and Baseline Estradiol Levels Are Independent Predictors for Initiation of Anastrozole in Hypogonadal Men on Clomiphene CitrateSorena Keihani, Nathan J Alder, Philip J Cheng, et al.
Infection|November 28, 2012
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF studyN C Schaper, M Dryden, P Kujath, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2004
Nanohydrodynamics simulations: an atomistic view of the Rayleigh-Taylor instabilityKai Kadau, Timothy C Germann, Nicolas G Hadjiconstantinou, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infectionsJ Alder, J Clement, J Meulbroek, et al.
Lancet (London, England)|February 25, 1989
Plasma-derived versus recombinant hepatitis B vaccinesJ B Kurtz, M J Alder, R T Mayon-White, et al.
Journal of Endocrinology and Diabetes|May 26, 2018
Toxic Immunoglobulin Light Chain Autoantibodies are Associated with a Cluster of Severe Complications in Older Adult Type 2 DiabetesMark B Zimering, N Mirkovic, M Pandya, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
In vitro and in vivo evaluations of A-80556, a new fluoroquinoloneJ J Clement, S K Tanaka, J Alder, et al.
Ophthalmic Epidemiology|August 15, 2024
Cost-Effectiveness of Addressing Retinopathy of Prematurity in RwandaConnor J Alder, Francis Mutangana, Victoria Phillips, et al.
Pageof 9